Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myanmar antimalarial efficacy study in uncomplicated falciparum and vivax malaria
ACTRN12611001245987Phase 4Not yet recruiting
- Sponsor
- Department of Medical Research
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine, artesunate + mefloquine, chloroquine in malaria, Malaria, sponsored by Department of Medical Research. Planned start Dec 2011; status: not yet recruiting.
02
Drugs
artemether + lumefantrineartesunate + mefloquinechloroquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12611001245987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001245987.